BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32422372)

  • 1. Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report.
    Calderon MA; Waserman S; Bernstein DI; Demoly P; Douglass J; Gagnon R; Katelaris CH; Kim H; Nelson HS; Okamoto Y; Okubo K; Virchow JC; DuBuske L; Casale TB; Canonica GW; Nolte H
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):2920-2936.e1. PubMed ID: 32422372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Allergen-specific immunotherapy : A brief overview in association with allergic conjunctivitis].
    Lill D; Bertlich M; Oppel E
    Ophthalmologie; 2024 Mar; 121(3):187-195. PubMed ID: 38324025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?
    Wandalsen GF; Aarestrup FM; Solé D
    Curr Opin Allergy Clin Immunol; 2024 Apr; 24(2):88-93. PubMed ID: 38359080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early expansion of allergen-responsive LAP
    Voskamp AL; de Jong NW; Jochems SP; Ozir-Fazalalikhan A; van Hengel ORJ; van der Vlugt LEPM; Stam KA; van den Berge M; Nawijn MC; Braunstahl GJ; Möller GM; van Wijk RG; Smits HH
    Allergy; 2024 Apr; 79(4):1060-1064. PubMed ID: 38169044
    [No Abstract]   [Full Text] [Related]  

  • 5. Allergic respiratory disease (ARD), setting forth the basics: proposals of an expert consensus report.
    Navarro AM; Delgado J; Muñoz-Cano RM; Dordal MT; Valero A; Quirce S;
    Clin Transl Allergy; 2017; 7():16. PubMed ID: 28533901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Management of Allergic Rhinitis.
    Klimek L; Mullol J; Ellis AK; Izquierdo-Domínguez A; Hagemann J; Casper I; Davis A; Becker S
    J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1399-1412. PubMed ID: 38851250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A EUFOREA Comment In Reference to Cost-Effectiveness Analysis of Inferior Turbinate Reduction and Immunotherapy in Allergic Rhinitis.
    Conti DM; Hellings PW; Smith PK; Scadding GK
    Laryngoscope; 2024 Apr; 134(4):E12-E13. PubMed ID: 38153194
    [No Abstract]   [Full Text] [Related]  

  • 8. [CLASSIFICATION OF RHINITIS AND TREATMENT FOR SEVERE ALLERGIC RHINITIS].
    Yamada T
    Arerugi; 2024; 73(2):155-159. PubMed ID: 38522928
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey.
    Alvaro-Lozano M; Sandoval-Ruballos M; Giovannini M; Jensen-Jarolim E; Sahiner U; Tomic Spiric V; Quecchia C; Chaker A; Heffler E; Klimek L; Brough H; Sturm G; Untersmayr E; Bonini M; Pfaar O
    Clin Transl Allergy; 2022 Jan; 12(1):e12097. PubMed ID: 35070270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digitally-enabled, person-centred care (PCC) in allergen immunotherapy: An ARIA-EAACI Position Paper.
    Pfaar O; Sousa-Pinto B; Papadopoulos NG; Larenas-Linnemann DE; Ordak M; Torres MJ; Mösges R; Klimek L; Zuberbier T; Matricardi PM; Berger UE; Berger M; Dramburg S; Mahler V; Toppila-Salmi SK; Bergmann KC; Ollert M; Tripodi S; Jutel M; Agache I; Eguiluz-Gracia I; Canonica GW; Akdis CA; Sokolowska M; Sofiev M; Shamji MH; Czarlewski W; Fonseca JA; Bedbrook A; Bousquet J
    Allergy; 2024 May; ():. PubMed ID: 38700063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers in allergen immunotherapy: Focus on eosinophilic inflammation.
    Kim CK; Callaway Z; Park JS; Pawankar R; Fujisawa T
    Asia Pac Allergy; 2024 Mar; 14(1):32-38. PubMed ID: 38482456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Success of Allergen-Specific Immunotherapy.
    Zissler UM; Schmidt-Weber CB
    Front Immunol; 2020; 11():1826. PubMed ID: 32983092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma.
    Breiteneder H; Peng YQ; Agache I; Diamant Z; Eiwegger T; Fokkens WJ; Traidl-Hoffmann C; Nadeau K; O'Hehir RE; O'Mahony L; Pfaar O; Torres MJ; Wang DY; Zhang L; Akdis CA
    Allergy; 2020 Dec; 75(12):3039-3068. PubMed ID: 32893900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EAACI Allergen Immunotherapy User's Guide.
    Alvaro-Lozano M; Akdis CA; Akdis M; Alviani C; Angier E; Arasi S; Arzt-Gradwohl L; Barber D; Bazire R; Cavkaytar O; Comberiati P; Dramburg S; Durham SR; Eifan AO; Forchert L; Halken S; Kirtland M; Kucuksezer UC; Layhadi JA; Matricardi PM; Muraro A; Ozdemir C; Pajno GB; Pfaar O; Potapova E; Riggioni C; Roberts G; Rodríguez Del Río P; Shamji MH; Sturm GJ; Vazquez-Ortiz M
    Pediatr Allergy Immunol; 2020 May; 31 Suppl 25(Suppl 25):1-101. PubMed ID: 32436290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in Allergy: A Pro/Con Review of Sublingual Allergen Immunotherapy and Allergic Asthma.
    Calderón MA; Bacharier LB
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1818-1825. PubMed ID: 33652134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021.
    Shimabukuro T
    Am J Transplant; 2021 Mar; 21(3):1326-1331. PubMed ID: 33641268
    [No Abstract]   [Full Text] [Related]  

  • 17. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020.
    Shimabukuro T
    Am J Transplant; 2021 Mar; 21(3):1332-1337. PubMed ID: 33641264
    [No Abstract]   [Full Text] [Related]  

  • 18. Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model.
    Incorvaia C; Al-Ahmad M; Ansotegui IJ; Arasi S; Bachert C; Bos C; Bousquet J; Bozek A; Caimmi D; Calderón MA; Casale T; Custovic A; De Blay F; Demoly P; Devillier P; Didier A; Fiocchi A; Fox AT; Gevaert P; Gomez M; Heffler E; Ilina N; Irani C; Jutel M; Karagiannis E; Klimek L; Kuna P; O'Hehir R; Kurbacheva O; Matricardi PM; Morais-Almeida M; Mosges R; Novak N; Okamoto Y; Panzner P; Papadopoulos NG; Park HS; Passalacqua G; Pawankar R; Pfaar O; Schmid-Grendelmeier P; Scurati S; Tortajada-Girbés M; Vidal C; Virchow JC; Wahn U; Worm M; Zieglmayer P; Canonica GW
    Allergy; 2021 Apr; 76(4):1041-1052. PubMed ID: 32869882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future.
    Pfaar O; Creticos PS; Kleine-Tebbe J; Canonica GW; Palomares O; Schülke S
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1791-1803. PubMed ID: 33966868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial.
    Demoly P; Corren J; Creticos P; De Blay F; Gevaert P; Hellings P; Kowal K; Le Gall M; Nenasheva N; Passalacqua G; Pfaar O; Tortajada-Girbés M; Vidal C; Worm M; Casale TB
    J Allergy Clin Immunol; 2021 Mar; 147(3):1020-1030.e10. PubMed ID: 32890575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.